iStock-538032878 hue adjustment.jpg

EPIVAX THERAPEUTICS, INC.

Science Without Fear

 

ABOUT US

EpiVax Therapeutics ('EVT'), an emerging biotechnology startup founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host. EVT’s pipeline includes a COVID-19 vaccine and a personalized bladder cancer vaccine.

For more information regarding EVT's cancer immunotherapies, please click here.

 

GET IN TOUCH

188 Valley Street, Suite 424, Providence, RI 02909

401-272-2123

  • LinkedIn
 

Subscribe Form

  • LinkedIn

©2020 by EpiVax Therapeutics, Inc.